Protective effect of CCR5 Δ32 base pair deletion in Crohn's disease.

被引：0
|
作者：
Zouali, H
Chamaillard, M
Colombel, JF
Belaiche, J
Côzard, JP
Tysk, C
Almer, S
Gassull, MA
Binder, V
Lesage, S
Thomas, G
Hugot, JP
机构：
[1] Fdn Jean Dausset, Paris, France
[2] Epimad, Lille, France
[3] Getaid, Liege, Belgium
[4] Ewggp Ibd, Paris, France
[5] Irebro Hosp, Irebro, Sweden
[6] Univ Hosp, Linkiping, Sweden
[7] Hosp Germans Trias & Pujol, Badalona, Spain
[8] Herlev Hosp, DK-2730 Herlev, Denmark
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1806
引用
收藏
页码：A333 / +
页数：2
相关论文
共 50 条
  • [31] Effect of CCR5Δ32 on HCV infection.
    Promrat, K
    McDermott, DH
    Gonzalez, CM
    Lessie, MD
    Merrell, MN
    Koziol, D
    Ghany, M
    Park, Y
    Alter, HJ
    Hoofnagle, JH
    Murphy, PM
    Liang, TJ
    HEPATOLOGY, 2001, 34 (04) : 230A - 230A
  • [32] Influence of CCR5, CCR5Δ32, RANTES and MIP chemokines in Wegener's granulomatosis (WG).
    Zhou, YH
    Huang, DR
    Farver, C
    Hoffman, GS
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S391 - S391
  • [33] CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis
    Kantarci, OH
    Morales, Y
    Ziemer, PA
    Hebrink, DD
    Mahad, DJ
    Atkinson, EJ
    Achenbach, SJ
    De Andrade, M
    Mack, M
    Ransohoff, RM
    Lassmann, H
    Bruck, W
    Weinshenker, BG
    Lucchinetti, CF
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 169 (1-2) : 137 - 143
  • [34] Frequency of the CCR5 gene 32-basepair deletion in Hispanic Mexicans
    Salas-Alanis, JC
    Mellerio, JE
    Ashton, GHS
    McGrath, JA
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1999, 24 (02) : 127 - 129
  • [35] The CCR5 32-bp deletion allele is rare in a Chinese population
    Wang, Fan
    Xiu, Mei Hong
    Cao, Lian Yuan
    Zhang, Xiang Yang
    SCHIZOPHRENIA RESEARCH, 2008, 101 (1-3) : 341 - 343
  • [36] Analysis of the CC chemokine receptor 5 (CCR5) Δ32 polymorphism in Behcet's disease
    Yang, X
    Ahmad, T
    Gogus, F
    Wallace, GR
    Madanat, W
    Kanawati, CA
    Stanford, MR
    Fortune, F
    Jewell, DP
    Marshall, SE
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2004, 31 (01): : 11 - 14
  • [37] Dual effect of CCR5 Delta 32 gene deletion in HIV-1-infected patients
    Garred, P
    EugenOlsen, J
    Iversen, AKN
    Benfield, TL
    Svejgaard, A
    Hofmann, B
    Koppelhus, U
    Pedersen, C
    Sorensen, AM
    Katzenstein, T
    Gerstoft, J
    Skinhoj, P
    Nielsen, JO
    Dickmeiss, E
    LANCET, 1997, 349 (9069): : 1884 - 1884
  • [38] Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease)
    Khorshid, Hamid Reza Khorram
    Manoochehri, Mehdi
    Nasehi, Leila
    Ohadi, Mina
    Rahgozar, Mehdi
    Kamali, Koorosh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2012, 15 (04) : 937 - 944
  • [39] Analysis of the CC chemokine receptor CCR5 δ32 mutation in Behcets's disease
    Yang, X
    Ahmad, T
    Gogus, F
    Wallace, G
    Madanat, W
    Kanawati, CA
    Yazici, H
    Marshall, SE
    Jewell, DP
    GUT, 2003, 52 : A55 - A55
  • [40] Mystery upon the origin for the selection of AIDS-protective CCR5Δ32
    Janvier, S
    Heveker, N
    M S-MEDECINE SCIENCES, 2005, 21 (6-7): : 577 - 579
12345